Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Revolve Group Inc ha un obiettivo di prezzo di consenso pari a $25.43, stabilito in base alle ultime valutazioni degli analisti di 21. Le ultime 3 valutazioni degli analisti sono state rilasciate da Morgan Stanley, Piper Sandler y Roth Capital il agosto 6, 2025, agosto 6, 2025 y agosto 5, 2025. Con un obiettivo di prezzo medio di $24.33 tra le Morgan Stanley, Piper Sandler y Roth Capital, c'è un implicito 9.61% upside per Revolve Group Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
08/06/2025 | 8.11% | Morgan Stanley | $22 → $24 | Maintains | Equal-Weight | |||
08/06/2025 | 12.61% | Piper Sandler | $22 → $25 | Maintains | Overweight | |||
08/05/2025 | 8.11% | Roth Capital | $19 → $24 | Maintains | Buy | |||
07/25/2025 | -0.9% | UBS | $19 → $22 | Maintains | Neutral | |||
07/22/2025 | 12.61% | Raymond James | $21 → $25 | Maintains | Outperform | |||
07/21/2025 | -0.9% | Morgan Stanley | $19 → $22 | Maintains | Equal-Weight | |||
06/06/2025 | 12.61% | Baird | $23 → $25 | Maintains | Neutral | |||
05/07/2025 | 3.6% | Baird | $25 → $23 | Maintains | Neutral | |||
05/07/2025 | 12.61% | Keybanc | $37 → $25 | Maintains | Overweight | |||
05/07/2025 | -14.41% | UBS | $22 → $19 | Maintains | Neutral | |||
05/07/2025 | -5.41% | Raymond James | $25 → $21 | Maintains | Outperform | |||
05/01/2025 | 12.61% | Baird | $26 → $25 | Maintains | Neutral | |||
04/17/2025 | -5.41% | Morgan Stanley | $29 → $21 | Maintains | Equal-Weight | |||
04/11/2025 | -0.9% | Piper Sandler | $35 → $22 | Maintains | Overweight | |||
04/10/2025 | 26.13% | Stifel | $40 → $28 | Maintains | Buy | |||
03/14/2025 | 35.14% | Jefferies | → $30 | Upgrade | Hold → Buy | |||
02/26/2025 | 62.16% | Roth MKM | $35 → $36 | Reiterates | Buy → Buy | |||
02/26/2025 | -14.41% | BMO Capital | $15 → $19 | Maintains | Market Perform | |||
02/26/2025 | 80.18% | Stifel | $41 → $40 | Maintains | Buy | |||
02/26/2025 | 17.12% | Barclays | $25 → $26 | Maintains | Equal-Weight | |||
01/23/2025 | 66.67% | Keybanc | → $37 | Upgrade | Sector Weight → Overweight | |||
12/11/2024 | 84.68% | Stifel | $35 → $41 | Maintains | Buy | |||
11/06/2024 | 35.14% | UBS | $25 → $30 | Maintains | Neutral | |||
11/06/2024 | 57.66% | BTIG | $30 → $35 | Maintains | Buy | |||
11/06/2024 | 57.66% | Roth MKM | $29 → $35 | Reiterates | Buy → Buy | |||
11/06/2024 | 53.15% | TD Cowen | $28 → $34 | Maintains | Buy | |||
11/06/2024 | 48.65% | Evercore ISI Group | $21 → $33 | Maintains | In-Line | |||
11/06/2024 | 57.66% | Piper Sandler | $30 → $35 | Maintains | Overweight | |||
11/06/2024 | 12.61% | Barclays | $17 → $25 | Upgrade | Underweight → Equal-Weight | |||
11/06/2024 | 48.65% | Baird | $24 → $33 | Maintains | Neutral | |||
10/30/2024 | 30.63% | Roth MKM | $26 → $29 | Maintains | Buy | |||
10/21/2024 | 17.12% | Morgan Stanley | $17 → $26 | Assumes | → Equal-Weight | |||
10/17/2024 | 12.61% | UBS | $21 → $25 | Maintains | Neutral | |||
10/02/2024 | -23.42% | Barclays | $15 → $17 | Maintains | Underweight | |||
08/27/2024 | 26.13% | TD Cowen | $25 → $28 | Maintains | Buy | |||
08/26/2024 | 26.13% | TD Cowen | $25 → $28 | Maintains | Buy | |||
08/23/2024 | 35.14% | Piper Sandler | → $30 | Assumes | → Overweight | |||
08/16/2024 | 17.12% | BTIG | $24 → $26 | Maintains | Buy | |||
08/14/2024 | 8.11% | Baird | $23 → $24 | Maintains | Neutral | |||
08/07/2024 | -14.41% | Wedbush | $19 → $19 | Reiterates | Neutral → Neutral | |||
08/07/2024 | -5.41% | Evercore ISI Group | $20 → $21 | Maintains | In-Line | |||
07/18/2024 | -36.94% | Barclays | $15 → $14 | Maintains | Underweight | |||
05/17/2024 | 12.61% | Needham | $25 → $25 | Reiterates | Buy → Buy | |||
05/09/2024 | -0.9% | UBS | $21 → $22 | Maintains | Neutral | |||
05/08/2024 | -32.43% | Barclays | $13 → $15 | Maintains | Underweight | |||
05/08/2024 | 17.12% | Roth MKM | $21 → $26 | Maintains | Buy | |||
05/08/2024 | -32.43% | BMO Capital | $13 → $15 | Maintains | Market Perform | |||
05/08/2024 | -14.41% | Wedbush | $17 → $19 | Maintains | Neutral | |||
05/08/2024 | 3.6% | Baird | $19 → $23 | Maintains | Neutral | |||
05/08/2024 | 12.61% | Needham | $23 → $25 | Maintains | Buy | |||
05/06/2024 | -9.91% | Evercore ISI Group | $17 → $20 | Maintains | In-Line | |||
04/26/2024 | 8.11% | Stifel | $20 → $24 | Maintains | Buy | |||
04/10/2024 | -9.91% | UBS | $16 → $20 | Maintains | Neutral | |||
04/03/2024 | 8.11% | BTIG | $22 → $24 | Maintains | Buy | |||
03/21/2024 | 12.61% | TD Cowen | $23 → $25 | Upgrade | Market Perform → Outperform | |||
02/29/2024 | -41.44% | Barclays | $12 → $13 | Maintains | Underweight | |||
02/28/2024 | — | Morgan Stanley | — | Initiates | → Equal-Weight | |||
02/28/2024 | -23.42% | Evercore ISI Group | $15 → $17 | Maintains | In-Line | |||
02/28/2024 | 1.35% | Piper Sandler | $21 → $22.5 | Maintains | Overweight | |||
02/28/2024 | -23.42% | Wedbush | $12 → $17 | Maintains | Neutral | |||
02/28/2024 | -5.41% | Raymond James | → $21 | Upgrade | Market Perform → Outperform | |||
02/28/2024 | 3.6% | Needham | $16 → $23 | Maintains | Buy | |||
02/23/2024 | -9.91% | Stifel | $18 → $20 | Maintains | Buy | |||
01/17/2024 | -5.41% | Piper Sandler | $16 → $21 | Upgrade | Neutral → Overweight | |||
01/10/2024 | -45.95% | Goldman Sachs | → $12 | Initiates | → Sell | |||
01/04/2024 | -23.42% | Baird | → $17 | Downgrade | Outperform → Neutral | |||
01/04/2024 | -23.42% | Jefferies | → $17 | Downgrade | Buy → Hold | |||
12/20/2023 | -5.41% | Roth MKM | $16 → $21 | Maintains | Buy | |||
12/14/2023 | -18.92% | Stifel | $16 → $18 | Maintains | Buy | |||
11/07/2023 | -36.94% | Evercore ISI Group | → $14 | Initiates | → In-Line | |||
11/03/2023 | -41.44% | BMO Capital | $17 → $13 | Maintains | Market Perform | |||
11/02/2023 | -27.93% | Piper Sandler | $20 → $16 | Maintains | Neutral | |||
11/02/2023 | -45.95% | Wedbush | $19 → $12 | Maintains | Neutral | |||
11/02/2023 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
11/02/2023 | -27.93% | Needham | $22 → $16 | Maintains | Buy | |||
11/02/2023 | -27.93% | Roth MKM | $20 → $16 | Maintains | Buy | |||
11/01/2023 | -27.93% | Roth MKM | $20 → $16 | Maintains | Buy | |||
10/25/2023 | -14.41% | Keybanc | $21 → $19 | Maintains | Overweight | |||
09/18/2023 | -9.91% | Stifel | → $20 | Reiterates | Buy → Buy | |||
08/04/2023 | -14.41% | Morgan Stanley | $19 → $19 | Reiterates | Equal-Weight → Equal-Weight | |||
08/04/2023 | -32.43% | Barclays | $17 → $15 | Maintains | Underweight | |||
08/03/2023 | -9.91% | Piper Sandler | $25 → $20 | Maintains | Neutral | |||
08/03/2023 | -14.41% | Morgan Stanley | $21 → $19 | Maintains | Equal-Weight | |||
08/03/2023 | -14.41% | Wedbush | → $19 | Reiterates | Neutral → Neutral | |||
08/03/2023 | -32.43% | Barclays | $17 → $15 | Maintains | Underweight | |||
08/03/2023 | -0.9% | Needham | $25 → $22 | Maintains | Buy | |||
08/03/2023 | -5.41% | Keybanc | $24 → $21 | Maintains | Overweight | |||
07/13/2023 | -5.41% | Morgan Stanley | $22 → $21 | Maintains | Equal-Weight | |||
06/20/2023 | 3.6% | Roth MKM | → $23 | Reiterates | → Buy | |||
05/22/2023 | -14.41% | TD Cowen | $30 → $19 | Downgrade | Outperform → Market Perform | |||
05/19/2023 | 12.61% | Needham | → $25 | Reiterates | Buy → Buy | |||
05/04/2023 | 21.62% | BTIG | $35 → $27 | Maintains | Buy | |||
05/04/2023 | -23.42% | BMO Capital | $22 → $17 | Maintains | Market Perform | |||
05/04/2023 | -14.41% | Wedbush | $27 → $19 | Maintains | Neutral | |||
05/04/2023 | 12.61% | Needham | $30 → $25 | Reiterates | → Buy | |||
05/04/2023 | 12.61% | Baird | $33 → $25 | Maintains | Outperform | |||
05/04/2023 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
05/04/2023 | -23.42% | Barclays | $20 → $17 | Maintains | Underweight | |||
05/04/2023 | 8.11% | Keybanc | $30 → $24 | Maintains | Overweight | |||
04/24/2023 | -9.91% | Barclays | $22 → $20 | Maintains | Underweight |
El último precio objetivo de Revolve Gr (NYSE:RVLV) fue comunicado por Morgan Stanley el agosto 6, 2025. La firma de analistas fijó un precio objetivo para $24.00 que espera RVLV a rise dentro de 12 meses (un posible 8.11% upside). 34 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Revolve Gr (NYSE:RVLV) fue proporcionada por Morgan Stanley, y Revolve Gr mantuvo su equal-weight calificación.
La última revisión al alza de Revolve Group Inc se produjo en marzo 14, 2025, cuando Jefferies elevó su precio objetivo a $30. Jefferies anteriormente tenía a hold para Revolve Group Inc.
La última revisión a la baja de Revolve Group Inc se produjo en enero 4, 2024, cuando Baird cambió su precio objetivo de N/A a $17 para Revolve Group Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Revolve Gr, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Revolve Gr se registró el agosto 6, 2025, por lo que la próxima calificación estará disponible en torno al agosto 6, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Revolve Gr (RVLV) fue un mantuvo con un precio objetivo de $22.00 a $24.00. El precio actual al que cotiza Revolve Gr (RVLV) es de $22.20, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.